Royal Bank of Canada’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,079
| Closed | -$68K | – | 6821 |
|
|
2024
Q4 | $68K | Sell |
7,079
-613
| -8% | -$5.89K | ﹤0.01% | 5070 |
|
|
2024
Q3 | $22K | Buy |
7,692
+8
| +0.1% | +$23 | ﹤0.01% | 5617 |
|
|
2024
Q2 | $23K | Buy |
7,684
+4,865
| +173% | +$14.6K | ﹤0.01% | 5634 |
|
|
2024
Q1 | $9K | Sell |
2,819
-20,551
| -88% | -$65.6K | ﹤0.01% | 5811 |
|
|
2023
Q4 | $79K | Buy |
23,370
+10,663
| +84% | +$36K | ﹤0.01% | 5225 |
|
|
2023
Q3 | $30K | Buy |
12,707
+4,401
| +53% | +$10.4K | ﹤0.01% | 5539 |
|
|
2023
Q2 | $14K | Buy |
8,306
+5,911
| +247% | +$9.96K | ﹤0.01% | 5905 |
|
|
2023
Q1 | $8K | Buy |
2,395
+711
| +42% | +$2.38K | ﹤0.01% | 6043 |
|
|
2022
Q4 | $9K | Sell |
1,684
-3,998
| -70% | -$21.4K | ﹤0.01% | 6113 |
|
|
2022
Q3 | $20K | Buy |
5,682
+3,028
| +114% | +$10.7K | ﹤0.01% | 5660 |
|
|
2022
Q2 | $7K | Sell |
2,654
-312
| -11% | -$823 | ﹤0.01% | 6075 |
|
|
2022
Q1 | $13K | Sell |
2,966
-3,007
| -50% | -$13.2K | ﹤0.01% | 6362 |
|
|
2021
Q4 | $41K | Buy |
5,973
+3,343
| +127% | +$22.9K | ﹤0.01% | 5957 |
|
|
2021
Q3 | $20K | Buy |
2,630
+661
| +34% | +$5.03K | ﹤0.01% | 6190 |
|
|
2021
Q2 | $20K | Sell |
1,969
-1,179
| -37% | -$12K | ﹤0.01% | 6071 |
|
|
2021
Q1 | $30K | Buy |
3,148
+2,409
| +326% | +$23K | ﹤0.01% | 5703 |
|
|
2020
Q4 | $8K | Buy |
+739
| New | +$8K | ﹤0.01% | 5939 |
|